The market did not tiptoe into Nordson’s report. The stock jumped 8% to about $334.70 in regular trading, a sharp repricing after an already strong 30 day run. The question for you is whether that move reflects emotion or the earnings reality.
The headline is clear. Nordson just printed record quarterly numbers with about $818 million in sales and adjusted earnings per share of $3.25, both backed by double digit organic growth and a 32% EBITDA margin. Add a 35% backlog increase and you can see why traders rushed in first and are asking detailed questions later.
Is Nordson now priced for perfection after this 8% jump, or are traders still misreading what these record margins and backlog really justify? See how the stock’s current multiples compare on our valuation analysis for Nordson
Q3 2026 Earnings Summary
- Total Revenue (Q3 2026 vs Q3 2025): US$817.7m vs. US$741.5m (up about 10%)
- Net Income (Excl. Extra Items) (Q3 2026 vs Q3 2025): US$152.8m vs. US$125.8m (up about 22%)
- Basic EPS (Q3 2026 vs Q3 2025): US$2.74 vs. US$2.23 (up about 23%)
- EBITDA Margin (Q3 2026 vs Q3 2025): 32% vs. the prior-year quarter, which was implied to be below the current level (record margin performance in Q3 2026)
Prefer clean charts instead of another wall of earnings tables and ratios? Get a visual snapshot of Nordson’s results and valuation drivers in the company report for Nordson.
Nordson bull case: backlog, ATS cycle and cash
Bulls argue Nordson is building a higher quality, higher growth portfolio driven by Advanced Technology Solutions, medical and recurring revenue. Q3 supports that claim in several concrete ways. ATS revenue of US$220m with ~31% organic growth and a 30% EBITDA margin shows the semiconductor and electronics engine is firing, and management explicitly describes ATS as at the peak of its cycle, not just bouncing off a low. Medical & Fluid Solutions delivered record US$231m revenue and a record 38% margin despite a prior divestiture headwind, which fits the thesis of a healthier medical mix. Company wide, organic growth of ~12%, a 32% EBITDA margin and 144% free cash flow conversion indicate the business is converting this cycle into cash, not just headline EPS. A 35% backlog increase plus raised full year guidance are the milestones bulls wanted on revenue visibility.
Nordson bear case: cyclicality, execution and expectations
The bear narrative focuses on cyclicality in semiconductor tools, guidance risk and rich expectations after a strong share price run. Q3 does not erase those concerns but it reframes them. Management openly calls ATS “in the peak of its cycle” and expects growth to normalize, which validates the cyclicality point even as current ATS performance exceeds earlier expectations. IPS is growing low single digits organically with flat margins, so not all end markets are sprinting. Bears worried that heavy investment and M&A such as Atrion or CapstanAG could dilute margins or strain the balance sheet. Instead, leverage is about 1.7x and EBITDA margin hit a record 32%, so that specific fear is not playing out in these numbers. The sharper risk now is execution against a higher bar. Backlog is up 35% and guidance is higher, which leaves less room for delays or order softness in later quarters.
After a record margin quarter and higher backlog, the key question from here is execution risk. Review our independent risk analysis for Nordson which shows 1 important warning sign.Take Control of Your Next Move
If Nordson’s record Q3 margins and backlog have your attention, register for free with Simply Wall St and add it to a Watchlist so you can track price against fair value and wait for a setup that fits your plan. Once you are in the stock, keep your decisions clear with the Portfolio Command Center that filters out noise and highlights only material changes to your holdings. For a longer term view, tap into the Community to see how other investors are thinking about Nordson and similar opportunities. By spotting potential catalysts and risks early, you give yourself the opportunity to act before the wider market reacts.
Seeking Alternatives Beyond Nordson?
Fresh ideas move quickly. Some stocks are building quiet momentum while others are dropping out of favor. Scan these curated lists before the crowd catches up and act now.
- Spot resilient cash generators before they are widely followed by screening for a curated list of solid balance sheet and fundamentals stocks (50 results) while it still flies under the radar for now.
- Ride the early wave of income opportunities by tracking a hand picked set of 12 dividend fortresses before yields change in response to increased interest from other investors.
- Position ahead of potential developments in AI hardware by reviewing a focused basket of 54 AI infrastructure stocks while it still matters and prices have not fully adjusted.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com